ALTEVAX
My visitor profile
ALTEVAX
Description of your activity
-
ALTEVAX is a Biotech company developing an innovative and disruptive immunotherapy platform for the treatment of cancer.
The platform is based on a non-toxic and versatile biopolymer adjuvant (synthetic melanin) that can be combined with a wide range of antigenic peptides for vaccine formulations. It has completed the proof-of-concept phase and demonstrated superior efficacy over existing vaccine adjuvants in numerous animal models.
More information
Social Networks
Mature Company
Michael HEIM
CFO
Antoine CARPENTIER
Main sector
- Biotechnology - Therapeutics and Diagnostics
Address
- Country : FRANCE
- City : Paris
- Zip Code : 75010
Participation objectives
Partnering objectives
- Out-licensing / collaboration opportunities, Financing / investment opportunities